SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Chang Hong) "

Sökning: WFRF:(Chang Hong)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
151.
  •  
152.
  • Thompson, Paul M., et al. (författare)
  • The ENIGMA Consortium : large-scale collaborative analyses of neuroimaging and genetic data
  • 2014
  • Ingår i: BRAIN IMAGING BEHAV. - 1931-7557. ; 8:2, s. 153-182
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA's first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.</p>
  •  
153.
  • van Thuijl, Hinke F., et al. (författare)
  • Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment
  • 2015
  • Ingår i: Acta Neuropathologica. - Springer Verlag (Germany). - 0001-6322 .- 1432-0533. ; 129:4, s. 597-607
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Temozolomide (TMZ) increases the overall survival of patients with glioblastoma (GBM), but its role in the clinical management of diffuse low-grade gliomas (LGG) is still being defined. DNA hypermethylation of the O (6) -methylguanine-DNA methyltransferase (MGMT) promoter is associated with an improved response to TMZ treatment, while inactivation of the DNA mismatch repair (MMR) pathway is associated with therapeutic resistance and TMZ-induced mutagenesis. We previously demonstrated that TMZ treatment of LGG induces driver mutations in the RB and AKT-mTOR pathways, which may drive malignant progression to secondary GBM. To better understand the mechanisms underlying TMZ-induced mutagenesis and malignant progression, we explored the evolution of MGMT methylation and genetic alterations affecting MMR genes in a cohort of 34 treatment-na less than ve LGGs and their recurrences. Recurrences with TMZ-associated hypermutation had increased MGMT methylation compared to their untreated initial tumors and higher overall MGMT methylation compared to TMZ-treated non-hypermutated recurrences. A TMZ-associated mutation in one or more MMR genes was observed in five out of six TMZ-treated hypermutated recurrences. In two cases, pre-existing heterozygous deletions encompassing MGMT, or an MMR gene, were followed by TMZ-associated mutations in one of the genes of interest. These results suggest that tumor cells with methylated MGMT may undergo positive selection during TMZ treatment in the context of MMR deficiency.</p>
  •  
154.
  • Wartenburger, Richard, et al. (författare)
  • Evapotranspiration simulations in ISIMIP2a-Evaluation of spatio-temporal characteristics with a comprehensive ensemble of independent datasets
  • 2018
  • Ingår i: Environmental Research Letters. - 1748-9326 .- 1748-9326. ; 13:7
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Actual land evapotranspiration (ET) is a key component of the global hydrological cycle and an essential variable determining the evolution of hydrological extreme events under different climate change scenarios. However, recently available ET products show persistent uncertainties that are impeding a precise attribution of human-induced climate change. Here, we aim at comparing a range of independent global monthly land ET estimates with historical model simulations from the global water, agriculture, and biomes sectors participating in the second phase of the Inter-Sectoral Impact Model Intercomparison Project (ISIMIP2a). Among the independent estimates, we use the EartH2Observe Tier-1 dataset (E2O), two commonly used reanalyses, a pre-compiled ensemble product (LandFlux-EVAL), and an updated collection of recently published datasets that algorithmically derive ET from observations or observations-based estimates (diagnostic datasets). A cluster analysis is applied in order to identify spatio-temporal differences among all datasets and to thus identify factors that dominate overall uncertainties. The clustering is controlled by several factors including the model choice, the meteorological forcing used to drive the assessed models, the data category (models participating in the different sectors of ISIMIP2a, E2O models, diagnostic estimates, reanalysis-based estimates or composite products), the ET scheme, and the number of soil layers in the models. By using these factors to explain spatial and spatio-temporal variabilities in ET, we find that the model choice mostly dominates (24%-40% of variance explained), except for spatio-temporal patterns of total ET, where the forcing explains the largest fraction of the variance (29%). The most dominant clusters of datasets are further compared with individual diagnostic and reanalysis-based estimates to assess their representation of selected heat waves and droughts in the Great Plains, Central Europe and western Russia. Although most of the ET estimates capture these extreme events, the generally large spread among the entire ensemble indicates substantial uncertainties.</p>
  •  
155.
  • Wheeler, Eleanor, et al. (författare)
  • Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis
  • 2017
  • Ingår i: PLoS medicine. - 1549-1676. ; 14:9, s. e1002383
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Glycated hemoglobin (HbA1c) is used to diagnose type 2 diabetes (T2D) and assess glycemic control in patients with diabetes. Previous genome-wide association studies (GWAS) have identified 18 HbA1c-associated genetic variants. These variants proved to be classifiable by their likely biological action as erythrocytic (also associated with erythrocyte traits) or glycemic (associated with other glucose-related traits). In this study, we tested the hypotheses that, in a very large scale GWAS, we would identify more genetic variants associated with HbA1c and that HbA1c variants implicated in erythrocytic biology would affect the diagnostic accuracy of HbA1c. We therefore expanded the number of HbA1c-associated loci and tested the effect of genetic risk-scores comprised of erythrocytic or glycemic variants on incident diabetes prediction and on prevalent diabetes screening performance. Throughout this multiancestry study, we kept a focus on interancestry differences in HbA1c genetics performance that might influence race-ancestry differences in health outcomes. Methods & findings: Using genome-wide association meta-analyses in up to 159,940 individuals from 82 cohorts of European, African, East Asian, and South Asian ancestry, we identified 60 common genetic variants associated with HbA1c. We classified variants as implicated in glycemic, erythrocytic, or unclassified biology and tested whether additive genetic scores of erythrocytic variants (GS-E) or glycemic variants (GS-G) were associated with higher T2D incidence in multiethnic longitudinal cohorts (N = 33,241). Nineteen glycemic and 22 erythrocytic variants were associated with HbA1c at genome-wide significance. GS-G was associated with higher T2D risk (incidence OR = 1.05, 95% CI 1.04–1.06, per HbA1c-raising allele, p = 3 × 10−29); whereas GS-E was not (OR = 1.00, 95% CI 0.99–1.01, p = 0.60). In Europeans and Asians, erythrocytic variants in aggregate had only modest effects on the diagnostic accuracy of HbA1c. Yet, in African Americans, the X-linked G6PD G202A variant (T-allele frequency 11%) was associated with an absolute decrease in HbA1c of 0.81%-units (95% CI 0.66–0.96) per allele in hemizygous men, and 0.68%-units (95% CI 0.38–0.97) in homozygous women. The G6PD variant may cause approximately 2% (N = 0.65 million, 95% CI 0.55–0.74) of African American adults with T2D to remain undiagnosed when screened with HbA1c. Limitations include the smaller sample sizes for non-European ancestries and the inability to classify approximately one-third of the variants. Further studies in large multiethnic cohorts with HbA1c, glycemic, and erythrocytic traits are required to better determine the biological action of the unclassified variants. Conclusions: As G6PD deficiency can be clinically silent until illness strikes, we recommend investigation of the possible benefits of screening for the G6PD genotype along with using HbA1c to diagnose T2D in populations of African ancestry or groups where G6PD deficiency is common. Screening with direct glucose measurements, or genetically-informed HbA1c diagnostic thresholds in people with G6PD deficiency, may be required to avoid missed or delayed diagnoses. © 2017 Public Library of Science. All Rights Reserved.
156.
  • Wheeler, Eleanor, et al. (författare)
  • Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations A transethnic genome-wide meta-analysis
  • 2017
  • Ingår i: PLoS Medicine. - PUBLIC LIBRARY SCIENCE. - 1549-1277 .- 1549-1676. ; 14:9
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background: Glycated hemoglobin (HbA1c) is used to diagnose type 2 diabetes (T2D) and assess glycemic control in patients with diabetes. Previous genome-wide association studies (GWAS) have identified 18 HbA1c-associated genetic variants. These variants proved to be classifiable by their likely biological action as erythrocytic (also associated with erythrocyte traits) or glycemic (associated with other glucose-related traits). In this study, we tested the hypotheses that, in a very large scale GWAS, we would identify more genetic variants associated with HbA1c and that HbA1c variants implicated in erythrocytic biology would affect the diagnostic accuracy of HbA1c. We therefore expanded the number of HbA1c-associated loci and tested the effect of genetic risk-scores comprised of erythrocytic or glycemic variants on incident diabetes prediction and on prevalent diabetes screening performance. Throughout this multiancestry study, we kept a focus on interancestry differences in HbA1c genetics performance that might influence race-ancestry differences in health outcomes.</p><p>Methods &amp; findings: Using genome-wide association meta-analyses in up to 159,940 individuals from 82 cohorts of European, African, East Asian, and South Asian ancestry, we identified 60 common genetic variants associated with HbA1c. We classified variants as implicated in glycemic, erythrocytic, or unclassified biology and tested whether additive genetic scores of erythrocytic variants (GS-E) or glycemic variants (GS-G) were associated with higher T2D incidence in multiethnic longitudinal cohorts (N = 33,241). Nineteen glycemic and 22 erythrocytic variants were associated with HbA1c at genome-wide significance. GS-G was associated with higher T2D risk (incidence OR = 1.05, 95% CI 1.04-1.06, per HbA1c-raising allele, p = 3 x 10-29); whereas GS-E was not (OR = 1.00, 95% CI 0.99-1.01, p = 0.60). In Europeans and Asians, erythrocytic variants in aggregate had only modest effects on the diagnostic accuracy of HbA1c. Yet, in African Americans, the X-linked G6PD G202A variant (T-allele frequency 11%) was associated with an absolute decrease in HbA1c of 0.81%-units (95% CI 0.66-0.96) per allele in hemizygous men, and 0.68%-units (95% CI 0.38-0.97) in homozygous women. The G6PD variant may cause approximately 2% (N = 0.65 million, 95% CI0.55-0.74) of African American adults with T2Dto remain undiagnosed when screened with HbA1c. Limitations include the smaller sample sizes for non-European ancestries and the inability to classify approximately one-third of the variants. Further studies in large multiethnic cohorts with HbA1c, glycemic, and erythrocytic traits are required to better determine the biological action of the unclassified variants.</p><p>Conclusions: As G6PD deficiency can be clinically silent until illness strikes, we recommend investigation of the possible benefits of screening for the G6PD genotype along with using HbA1c to diagnose T2D in populations of African ancestry or groups where G6PD deficiency is common. Screening with direct glucose measurements, or genetically-informed HbA1c diagnostic thresholds in people with G6PD deficiency, may be required to avoid missed or delayed diagnoses.</p>
  •  
157.
  •  
158.
  • Xu, Guangfu, et al. (författare)
  • Evaluation of variable compression ratio (VCR)and variable valve timing (VVT)strategies in a heavy-duty diesel engine with reactivity controlled compression ignition (RCCI)combustion under a wide load range
  • 2019
  • Ingår i: Fuel. - Elsevier. - 0016-2361. ; 253, s. 114-128
  • Tidskriftsartikel (refereegranskat)abstract
    • Variable compression ratio (VCR)and variable valve timing (VVT)are two effective strategies to adjust the effective compression ratio, which is beneficial for controlling the combustion process of advanced combustion modes. In this study, systematic evaluation of the two strategies was conducted based on reactivity controlled compression ignition (RCCI)engine in terms of combustion process control, fuel efficiency, and emission characteristics. By coupling an updated KIVA-3V code with the genetic algorithm, the combustion of a heavy-duty RCCI engine with VCR and VVT strategies was respectively optimized, aiming to simultaneously realize high fuel efficiency and low emissions. The optimal VCR and VVT strategies were compared under a wide load range. The results indicate that, at low and mid loads, high effective compression ratio, large premix ratio, and early fuel injection can be utilized to realize Euro 6 nitrogen oxides (NO x )limit with ultra-low soot emissions and low fuel consumption for both VCR and VVT strategies. The increase of load from low to mid narrows the optimal range of exhaust gas recirculation (EGR)rate for VVT strategy whereas the range for VCR strategy is still wide. At high load, compared to VVT strategy, a further decreased effective compression ratio can be utilized for VCR strategy, which allows early fuel injection, leading to the improvements of fuel efficiency and soot emissions. This suggests that the VCR strategy is more practical for high-load operation of RCCI combustion and the commercialization the RCCI engine in the future compared to VVT strategy.
  •  
159.
  • Xu, Jing-Hao, et al. (författare)
  • Briaviolides K-N, New Briarane-Type Diterpenoids from Cultured Octocoral Briareum violaceum
  • 2018
  • Ingår i: Marine Drugs. - MDPI. - 1660-3397 .- 1660-3397. ; 16:3
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Four new briarane diterpenoids, briaviolides K-N (1-4), have been obtained from the cultured-type octocoral Briareum violaceum. Using a spectroscopic approach, the structures of briaranes 1-4 were identified. This study employed an in vitro model of lipopolysaccharide (LPS)-induced inflammation in the murine macrophage RAW264.7 cell line, and found that among the four briaranes, briarane 2 possessed anti-inflammatory activity against inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) protein expressions in cells. In addition, principal component analysis using the chemical global positioning system (ChemGPS) for natural products (ChemGPS-NP) was employed in order to analyze the structure-activity relationship (SAR), and the results indicated that the ring conformation of the compound has a leading role in suppressing the expressions of pro-inflammatory iNOS and COX-2 proteins in macrophages.</p>
  •  
160.
  • Yang, Rong, et al. (författare)
  • Oriented Quasi-2D Perovskites for High Performance Optoelectronic Devices
  • 2018
  • Ingår i: Advanced Materials. - WILEY-V C H VERLAG GMBH. - 0935-9648 .- 1521-4095. ; 30:51
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Quasi-2D layered organometal halide perovskites have recently emerged as promising candidates for solar cells, because of their intrinsic stability compared to 3D analogs. However, relatively low power conversion efficiency (PCE) limits the application of 2D layered perovskites in photovoltaics, due to large energy band gap, high exciton binding energy, and poor interlayer charge transport. Here, efficient and water-stable quasi-2D perovskite solar cells with a peak PCE of 18.20% by using 3-bromobenzylammonium iodide are demonstrated. The unencapsulated devices sustain over 82% of their initial efficiency after 2400 h under relative humidity of approximate to 40%, and show almost unchanged photovoltaic parameters after immersion into water for 60 s. The robust performance of perovskite solar cells results from the quasi-2D perovskite films with hydrophobic nature and a high degree of electronic order and high crystallinity, which consists of both ordered large-bandgap perovskites with the vertical growth in the bottom region and oriented small-bandgap components in the top region. Moreover, due to the suppressed nonradiative recombination, the unencapsulated photovoltaic devices can work well as light-emitting diodes (LEDs), exhibiting an external quantum efficiency of 3.85% and a long operational lifetime of approximate to 96 h at a high current density of 200 mA cm(-2) in air.</p>
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (15)
Typ av publikation
tidskriftsartikel (150)
konferensbidrag (7)
forskningsöversikt (2)
bokkapitel (1)
Typ av innehåll
refereegranskat (158)
övrigt vetenskapligt (6)
Författare/redaktör
Bathe, S. (97)
Aphecetche, L. (97)
Averbeck, R. (97)
Buesching, H. (97)
Chujo, T. (97)
Glenn, A. (97)
visa fler...
Esumi, S. (97)
Hamagaki, H. (97)
Lebedev, A. (97)
Alexander, J (97)
Belikov, S (97)
Hong, B (97)
Akiba, Y., (97)
Bazilevsky, A, (97)
Bumazhnov, V. (97)
Chiu, M, (97)
Bassalleck, B (97)
Bunce, G (97)
Cianciolo, V (97)
David, G (97)
Denisov, A (97)
Deshpande, A (97)
Drees, A (97)
Durum, A (97)
Fraenkel, Z (97)
Franz, A (97)
Goto, Y (97)
He, X (97)
Homma, K (97)
Ichihara, T (97)
Imai, K (97)
Ishihara, M (97)
Jia, J (97)
Kametani, S (97)
Kozlov, A (97)
Kurita, K (97)
Kwon, Y (97)
Lacey, R (97)
Mao, Y (97)
Matathias, F (97)
Chernichenko, S. (97)
Gustafsson, Hans-Åke ... (96)
Baublis, V (96)
Butsyk, S (96)
Dietzsch, O (96)
En'yo, H (96)
Hayano, R (96)
Kistenev, E (96)
Miake, Y (96)
Milov, A (96)
visa färre...
Lärosäte
Lunds universitet (112)
Karolinska Institutet (15)
Uppsala universitet (13)
Linköpings universitet (8)
Umeå universitet (6)
Göteborgs universitet (5)
visa fler...
Kungliga Tekniska Högskolan (4)
Stockholms universitet (2)
Örebro universitet (1)
Högskolan i Jönköping (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (160)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (116)
Medicin och hälsovetenskap (32)
Teknik (6)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy